ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 90 filers reported holding ONCOCYTE CORP in Q4 2021. The put-call ratio across all filers is 0.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $126,000 | -38.2% | 84,368 | -29.7% | 0.00% | -50.0% |
Q4 2021 | $204,000 | -52.2% | 120,000 | 0.0% | 0.00% | -33.3% |
Q3 2021 | $427,000 | -38.0% | 120,000 | 0.0% | 0.00% | -25.0% |
Q2 2021 | $689,000 | +10.6% | 120,000 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $623,000 | +117.1% | 120,000 | 0.0% | 0.00% | +100.0% |
Q4 2020 | $287,000 | +9466.7% | 120,000 | +7519.0% | 0.00% | – |
Q2 2020 | $3,000 | +50.0% | 1,575 | +71.2% | 0.00% | – |
Q1 2020 | $2,000 | – | 920 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BROADWOOD CAPITAL INC | 1,093,219 | $6,833,000 | 1.15% |
HUNTINGTON NATIONAL BANK | 10 | $0 | 0.00% |
CITIGROUP INC | 642 | $4,000 | 0.00% |
Sonora Investment Management, LLC | 50 | $0 | 0.00% |
BARCLAYS PLC | 206 | $1,000 | 0.00% |
BLACKROCK ADVISORS LLC | 96 | $1,000 | 0.00% |